Does Magnesium Glycinate Cause Digestive Side Effects? What the Evidence Says

Magnesium supplements have a reputation problem. Any given night, millions of people take them for sleep, muscle cramps, or just to top off a dietary shortfall. Their first few days can be memorable for the wrong reason: urgent trips to the bathroom, bloating, and the creeping sense that the cure might be worse than whatever they were trying to fix. Usually the culprit is not the magnesium itself. It is the form it arrives in. Cheap, common magnesium oxide pulls water into the colon through a straightforward osmotic mechanism, and it is absorbed so poorly that only a sliver makes it into circulation. Citrate does something similar. That is why both show up in over-the-counter laxatives. A chelated version, magnesium glycinate, binds the mineral to the amino acid glycine and is widely sold as the gentler alternative. Whether the evidence actually backs that claim turns out to be a more interesting question than the supplement labels let on.

In the studies that have compared them head to head, glycinate does appear to cause fewer digestive side effects than oxide or citrate. But “fewer” is not “none.” The tolerability story comes with an absorption profile that challenges at least some of the assumptions people carry into the supplement aisle. Here, the details matter.

Why magnesium supplements cause diarrhea in the first place

Start with why most magnesium supplements irritate the gut at all if you want to understand why glycinate might be different. Absorption efficiency is the problem. Or, more precisely, the absence of it.

Swallow magnesium oxide and only about 4 percent of the elemental mineral actually crosses the intestinal wall, according to work by Ranade and Somberg. Roughly 95-plus percent of the dose sits in the GI tract, where it acts as an osmotic agent. Unabsorbed ions in the colon pull water in from surrounding tissues, increasing intestinal flow and producing the laxative effect anyone who has ever taken a high dose of milk of magnesia will recognise. This is not a side effect in the conventional sense. It is the direct, predictable consequence of poor absorption, and the mechanism is well characterized in the gastroenterology literature.

Citrate is meaningfully better absorbed than oxide. One trial published in 2003 found it more bioavailable than several other preparations. Still, a substantial fraction of its payload ends up unabsorbed in the gut. Writing in the Journal of the American Heart Association, Bakker and colleagues put the problem bluntly in 2022: “The intestinal solubility likely plays an important role in bioavailability of magnesium. Gastrointestinal adverse events induced by magnesium supplements are frequently reported. Particularly, osmotic diarrhea is often a result of high dosages of magnesium from dietary supplements.”

Per the Institute of Medicine and a 2021 review by Pardo and colleagues, the tolerable upper intake level for supplemental magnesium sits at 350 mg per day. Not because magnesium itself is toxic at that dose. Because that is roughly the threshold where diarrhea becomes common enough to register as a population-level concern. With most unchelated forms, the bowel gives out before the bloodstream gets what it needs.

What makes glycinate different, in theory

Magnesium glycinate, also called bisglycinate, pairs each magnesium ion with two glycine molecules. Glycine is a small, non-essential amino acid the body absorbs readily in the small intestine through dedicated dipeptide transport pathways, primarily the PepT1 transporter, which shuttles small peptides across the brush-border membrane in the upper GI tract. The theoretical advantage is simple: if the mineral can hitch a ride on the same transporter that handles glycine, it gets absorbed higher in the gut. Less unabsorbed magnesium reaches the colon to set off an osmotic purge.

Elegant theory. The experimental record, what actually happens when you give chelated magnesium to human volunteers and measure what comes out, is more useful for making a purchasing decision.

What the head-to-head evidence actually shows

David Pajuelo and colleagues at Bionos Biotech, publishing in Nutrients in 2024, ran the most informative study on this question to date. Double-blind, randomized, crossover: 40 healthy volunteers, four different formulations (oxide, citrate, bisglycinate, and a microencapsulated product called MAGSHAPE), each participant cycling through all four with washout periods between them. Everyone served as their own control.

Revealing findings, and they do not line up neatly with the glycinate-is-gentler story. Volunteers reported less increase in intestinal flow, the objective measure most closely tied to diarrhea, with bisglycinate than with oxide or citrate. The incidence of increased intestinal flow ran 50 to 100 percent higher with citrate and oxide compared to the microencapsulated formulation, and bisglycinate landed somewhere in between. But the same study also found that bisglycinate produced more reports of stomach heaviness than several other forms tested, including the microencapsulated version.

That complicates the simple narrative. Glycinate seems easier on the lower GI tract, less diarrhea, less urgency. It is not necessarily easier on the stomach itself. The glycine component, the trial’s authors suggested, may sit somewhat heavily in the stomach for a subset of users while aiding absorption. They stopped short of proposing a mechanism.

The other notable result from Pajuelo’s work concerned absorption, and here the bisglycinate numbers were less flattering than the marketing copy implies. Across four measurement points in the six-hour window after ingestion, bisglycinate produced no statistically significant increase in plasma magnesium compared to baseline. The microencapsulated form, by contrast, raised plasma magnesium by 7.5 to 8.8 percent at every time point. This does not mean bisglycinate is not absorbed. Plasma magnesium is tightly regulated, and tissue uptake can mask acute serum changes. But the head-to-head absorption advantage glycinate enjoys in bench-top dissolution work has been hard to reproduce in well-controlled human trials.

Testing magnesium bisglycinate against placebo in adults reporting poor sleep, a separate 2025 study in Nature and Science of Sleep produced much more encouraging tolerability numbers: 93 percent of participants in the magnesium arm reported no adverse events, zero serious adverse events were recorded, and two placebo-group participants withdrew due to stomach pain. At the doses used there, typical of what a consumer would take for sleep support, glycinate appears remarkably well tolerated.

What clinicians say

Gastroenterologists who see supplement-related GI complaints in practice tend to align with the broad shape of the evidence. Saurabh Sethi, a gastroenterologist, summarized: “Magnesium glycinate is often better tolerated. The magnesium is combined with the amino acid glycine, making it more gentle on the gastrointestinal tract and more easily absorbed into the body.”

Quoted in the same piece, Ayanna Lewis, a gastroenterologist at Mount Sinai, added a qualification that cuts across the entire category: “Regardless of the formulation, if you take enough, it will have a laxative effect.” The form matters. Glycinate does appear to raise the threshold at which side effects appear. Dose matters more. Take 800 mg of even the best-absorbed magnesium, and your bowel will eventually notice.

What this means if you are trying to pick a magnesium supplement

For someone standing in the supplement aisle, or more likely scrolling through an online marketplace with too many tabs open, the evidence supports a few practical takeaways.

Tried magnesium citrate or oxide and got diarrhea? Switching to glycinate is a reasonable move with some empirical backing. The Pajuelo 2024 data show reduced lower-GI side effects, and the 2025 sleep trial’s 93 percent adverse-event-free rate is encouraging. Glycinate is not side-effect-proof. A minority of users will still get bloating or stomach discomfort. But the odds of tolerating it are markedly better than with the cheaper salts.

Dose still dominates the equation. Starting at 100 to 200 mg of elemental magnesium from glycinate and titrating up slowly over two weeks gives the GI tract time to adapt. Taking it with food rather than on an empty stomach may also help: the presence of other nutrients in the small intestine slows transit and gives the PepT1 transporter more time to do its job. Consult your doctor before starting any supplement.

If glycinate still causes problems, other chelated forms are worth considering. Magnesium malate and magnesium taurate both use amino acid or organic acid carriers. The microencapsulated formulations studied by Pajuelo’s group represent a different approach entirely, physically coating the mineral to delay release until it reaches the small intestine’s absorption-friendly environment. Less studied than glycinate, they occupy the same low-side-effect niche.

Need magnesium primarily for constipation relief? Do not switch to glycinate. The laxative effect of oxide and citrate is, in that context, the intended effect. Glycinate is the form you pick when you want the mineral without the bathroom drama.

What the evidence does not yet tell us

The gaps in the literature are worth being honest about. Pajuelo’s 2024 study used 40 participants. Enough for a crossover design to detect within-person differences, but not enough to characterize rare side effects or to parse subgroups by age, sex, or baseline magnesium status. Larger and more representative of real-world use, the 2025 sleep trial was not designed as a head-to-head comparison of forms. Its adverse-event data for glycinate are reassuring, but they cannot tell us whether citrate would have performed similarly in the same population.

Longer-term tolerability data, beyond the weeks-to-months window of these trials, are essentially absent. People who take bisglycinate daily for years are doing so in something of an evidence vacuum on chronic GI safety, though there is no particular reason to suspect a problem given that glycine is a normal dietary amino acid.

Absorption kinetics need more work too. That Pajuelo and colleagues could not detect a significant plasma magnesium increase at any time point, while the microencapsulated product produced measurable rises, suggests the PepT1-mediated pathway, though real, may operate more slowly than the paracellular diffusion that drives uptake of more soluble salts. A 2025 study of marine magnesium bisglycinate by Annex Publishers reported a 27 percent peak serum absorption at the four-hour mark. Meaningful. But that was an acute-dosing study in a different population, and the contrast with Pajuelo’s null result underscores how much we still do not know about the conditions that optimize glycinate absorption.

Bottom line

Magnesium glycinate is not a digestive magic bullet, and the label claims about superior absorption have not been consistently borne out in human trials. But as a practical matter, and this is what most people actually care about, it does appear to produce fewer episodes of diarrhea and intestinal urgency than the oxide and citrate forms that anchor the low-cost end of the supplement market. Had a bad experience with cheaper magnesium? Glycinate is worth a try. Start low, go slow, and keep expectations calibrated to what the evidence can actually support.

References

1. Pajuelo D, Meissner JM, Negra T, et al. Comparative clinical study on magnesium absorption and side effects after oral intake of microencapsulated magnesium (MAGSHAPE microcapsules) versus other magnesium sources. Nutrients 16(24):4367. 2024. https://doi.org/10.3390/nu16244367
2. Bakker MF, et al. Effects of magnesium citrate, magnesium oxide, and magnesium sulfate on arterial stiffness. J Am Heart Assoc. 2022. https://doi.org/10.1161/JAHA.121.021783
3. Magnesium bisglycinate supplementation in healthy adults reporting poor sleep: a randomized, placebo-controlled trial. Nat Sci Sleep. 2025. https://doi.org/10.2147/NSS.S524348
4. Walker AF, Marakis G, Christie S, Byng M. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnes Res 16(3):183-191. 2003. https://pubmed.ncbi.nlm.nih.gov/14596323
5. Ranade VV, Somberg JC. Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humans. Am J Ther 8(6):345-357. 2001.
6. Pardo MR, Garicano Vilar E, San Mauro Martín I, Camina Martín MA. Bioavailability of magnesium food supplements: a systematic review. Nutrition 89:111294. 2021. https://doi.org/10.1016/j.nut.2021.111294